Literature DB >> 4332134

Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of tyrpsin on L cell-borne Sendai virus.

M Homma.   

Abstract

Sendai virus grown in fertile eggs (egg Sendai) infects L cells in which the synthesis of L Sendai (grown in L cells) occurs by the one-step mechanism. L Sendai is not infectious for L cells when tested by the tube titration method although it is infectious for chick embryos. When L cells infected with egg Sendai were dispersed by trypsin and plated on a monolayer culture of L cells, the viral agents spread to the adjacent recipient cells in which the synthesis of L Sendai occurred. The newly infected L cells became infectious for L cells again by trypsin treatment. Kinetic experiments suggested that the target of trypsin is the mature virus, of L Sendai nature, just budding from the L-cell surface. By using an immunofluorescent cell-counting technique, recovery of the infectivity of L Sendai for L cells due to a direct enzymatic action of trypsin was demonstrated. Under the optimal condition, the infectivity increased 1,000-fold for L cells and 10-fold for chick embryos, and both the titers could favorably be compared. No increasing effect of trypsin was observed on the infectivity of egg Sendai. Density centrifugation studies revealed a difference between egg Sendai and L Sendai in the density. Trypsin treatment which induced the maximal enhancement of L Sendai infectivity did not affect both the densities, showing that variations of Sendai virus in the infectivity for L cells and in the density are independent types of host-controlled modification.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332134      PMCID: PMC376239     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  A variant Sendai virus, infectious to egg embryos but not to L cells. III. Growth characteristics of myxoyiruses in tissue culture.

Authors:  N ISHIDA; M HOMMA
Journal:  Tohoku J Exp Med       Date:  1960-12-25       Impact factor: 1.848

2.  A particular binding of L cell-grown Sendal virus by host L cells. (Growth characteristics of myxoviruses in tissue culture. 5th).

Authors:  M HOMMA
Journal:  Tohoku J Exp Med       Date:  1961-02-25       Impact factor: 1.848

3.  Host-controlled variation observed with Sendai virus grown in mouse fibroblast (L) cells.

Authors:  N ISHIDA; M HOMMA
Journal:  Virology       Date:  1961-08       Impact factor: 3.616

4.  Use of potassium tartrate for equilibrium density-gradient centrifugation of animal viruses.

Authors:  J F MCCREA; R S EPSTEIN; W H BARRY
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

5.  A host-induced modification of hemagglutinating virus of Japan (HVJ, Sendai virus) in its hemolytic and cytopathic activity.

Authors:  T MATSUMOTO; K MAENO
Journal:  Virology       Date:  1962-08       Impact factor: 3.616

6.  Effect of trypsin on viral susceptibility of Vero cell cultures--cercopithecus kidney line.

Authors:  H Ito; Y Morimoto; I Iwase; Y Doi; T Sanpe
Journal:  Jpn J Med Sci Biol       Date:  1970-08

7.  The action of protease on influenza A2 virus.

Authors:  F Biddle
Journal:  J Gen Virol       Date:  1968-01       Impact factor: 3.891

8.  Enhancement of vaccinia virus plaque formation by trypsin.

Authors:  G E Gifford; D G Klapper
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

9.  Isolation of hemagglutinin and neuraminidase subunits of hemagglutinating virus of Japan.

Authors:  K Maeno; T Yoshida; M Iinuma; Y Nagai; T Matsumoto
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

10.  Plaque enhancement of enteroviruses by magnesium chloride, cysteine, and pancreatin.

Authors:  C Wallis; F Morales; J Powell; J L Melnick
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

View more
  37 in total

1.  Characterization of the polypeptides synthesized in cells infected with a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.

Authors:  Y Kimura; C Orvell; E Norrby
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Temperature-sensitive virus derived from BHK cells persistently infected with HVJ (Sendai virus).

Authors:  Y Kimura; Y Ito; K Shimokata; Y Nishiyama; I Nagata
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

3.  High-titer replication of nondefective Sendai virus in MDBK cells.

Authors:  N G Famulari; E Fleissner
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

4.  Transfection of Sendai virus F gene cDNA with mutations at its cleavage site and HN gene cDNA into COS cells induces cell fusion.

Authors:  H Taira; T Sato; H Segawa; M Chiba; T Katsumata; K Iwasaki
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 5.  Viral pathogenesis and molecular biology.

Authors:  A S Huang
Journal:  Bacteriol Rev       Date:  1977-12

6.  Rotavirus isolation and cultivation in the presence of trypsin.

Authors:  L A Babiuk; K Mohammed; L Spence; M Fauvel; R Petro
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

7.  A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA.

Authors:  Y Kazuyama; S M Lee; K Amamiya; F Taguchi
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

8.  Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein.

Authors:  Kelly Ann Meulendyke; Mark Allen Wurth; Richard O McCann; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Authors:  M Tashiro; Y Yokogoshi; K Tobita; J T Seto; R Rott; H Kido
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.